8.30 USD
↘ 0.38 (4.41%)LIVE (AS OF 03:14 PM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
Market: OPEN
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $8.30 per share. The technical outlook is "Neutral" and the fundamental picture shows "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (104.2%) and a bullish Golden Cross on the moving averages. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jul 15, 2026.
Open?$8.61
High?$8.85
Low?$8.12
Prev. Close?$8.68
Volume?93.7K
Avg. Volume?400.3K
VWAP?$8.32
Rel. Volume?0.23x
Bid / Ask
Bid?$7.13 × 100
Ask?$9.65 × 100
Spread?$2.52
Midpoint?$8.39
Valuation & Ratios
Market Cap?255.0M
Shares Out?29.4M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-1.72
EPS?-$5.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
255.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?31
Piotroski F-Score?0/9Weak
Altman Z-Score?-5.08Distress
Confidence?70%Moderate
Short InterestHigh
Short % of Float?15.65%High
Short Interest?1.9M
Days to Cover?4.9
Free Float12.1M
Avg Daily Volume384.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.65Strong
Cash Ratio?7.44Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.72CHEAP▾
S&P97
P/S?143.68HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
S&P97
EV/Sales?76.84HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?104.2%STRONG▾
Peers50
S&P97
ROA?-53.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-77374000
Enterprise Value?$136.4M
Fundamentals ratios updated end of day